The prevalence of high-risk HPV infection in pregnant women from Morelos, México;Prevalencia de infección por virus de papiloma humano (VPH) de alto riesgo y factores asociados en embarazadas derechohabientes del IMSS en el estado de Morelos

Salud Publica de Mexico

Volumn 47, Issue 6, 2005, Pages 423-429

  Hernández Girón, Carlos ^a   Smith, Jennifer S ^b   Lorincz, Attila ^c   Cháidez, Emilio Arreola ^a   Lazcano, Eduardo ^a   Hernández Ávila, Mauricio ^a   Salmerón, Jorge ^d  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Digene Corporation   (United States)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Epidemiology; Human papillomavirus (hpv); Mexico; Pregnancy

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; INFECTION; LIFESPAN; MAJOR CLINICAL STUDY; MEXICO; ONCOGENE; POPULATION RESEARCH; PREGNANCY; PRENATAL CARE; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALITY; SMOKING; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MEXICO; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; RISK FACTORS;

EID: 31944437435     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest 2002;20(7-8):1080-5.
2. Franco EL, Franco ED, Ferenczy A: Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001;164(7).
3. Vizcaíno A, Moreno V, Bosch F, Muñoz N, Barros X, Parkin D. International trends in the incidence of cervical cancer. Int J Cancer; 1998;75:536-45.
4. Dirección General de Información y Evaluación del Desempeño. Secretaría de Salud. Salud: México 2001: Cancer Cervicouterino. SSA 2002.
5. Muñoz N, Bosch F, Sanjosé S. Valadui P, Tormo J, Ascunce N et al. El virus del papiloma humano en la etiología del cáncer cervicouterino. Bol Of Sanit Panam 1993;115(84):301-308.
6. Tay S, Jenkins D, Singer A. Natural killer cells in cervical intraepithelial neoplasia and human infection. Br J Obst Gynecol 1987;94:901-906.
7. Ho G, Bierman R, Beardsley L, Chang C, Burk D. Natural history of cervical papillomavirus infection in young women. N Eng J Med 1998;338:423-428.
8. Ley C, Bauer H, Reighold A. Determinants of HPV infections in young women. J Ntl Cancer Inst 1991;3:997-1000.
9. Tchabo J, Brinton L, Copeland C. Epp J. Determinants of genital human papillomaviruses infection in low-income women in Washington D.C. Sex Trans Dis 1993;20(5):279-285.
10. Syrjanen K. Human papillomavirus in genital carcinogenesis. Sex Trans Dis 1994; 21(2):86-89.
11. Chang J, Scneider A, Smith E, Blettner M, Wahrendorf J, Turek L. Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol 1996;60:355-362.
12. Smith E, Johnson S, Cripe T, Perlman S, MacGuiness G. Perinatal transmission and maternal risk of human papillomavirus infection. Cancer Detec Prev 1995;19:196-207.
13. Pakarian F, Kaye J, Cason J, Kell B, Jewers R, Derias N et al. Cancer associated human papillomaviruses: perinatal transmission and persistence. British J Obst & Gynaecol 1994; 101(6):514-517.
14. Lorincz A. Hybrid CaptureTM method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Report 1996; 7:1-5.
15. Soares VR, Nieminen P, Aho M, Vesterinen E, Vaheri A, Pavoneen J: HPV DNA in unselected pregnant and non pregnant. Int J STD AIDS. 1990;1(4):276-8
16. Armbruster-Moraes E, Ioshimoto L, Leao E, Zugaib M. Prevalence of high-risk HPV in the lower genital tract of Brazilian gravidas. Int J Gynaecol Obstet 2000;69(3):223-27.
17. Hellman L, Prtichard J. Fisiología del Embarazo en Williams Obstetricia. México: Editorial Salvat, 1980.
18. Nobbenhuis M, Helmorhorst T, van den Brule A, Bezemer P, Voorhorst F, Meijer C. High-risk human papilloma clearance in pregnant women: trends for lower clearance during pregnancy with a catch-up postpartum. BJC 2002;87:75-80.
19. Arena S, Marchoni M, Ubertosi M, Frega A, Arena G, Villani C: HPV and pregnancy: diagnosis, methods, transmission and evolution. Minerva Ginecol 2002;54(3):225-37.
20. Fife K, Katz P, Roush J, Handy VD, Brown D, Hansell R: Cancer associated human papillomavirus types are selectively increased in the cervic of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996;174:1487-93
21. Fife K, Katz B, Brizendine E, Brown D. Cervical HPV DNA persist through pregnancy and decreases in the postpartum period. Am J Obstet Gynecol 1999;180:1110-14.
22. Morrison E, Gammon M, Goldberg G, Vermund S, Burk R. Pregnancy and cervical infection with human papillomaviruses. Int J Gynecol Obstet 1996;54(2):125-30.
23. Eppel W, Worda C, Frigo P, Ulm M, Kucera E, Czerwenka K. Human papillomavirus in the cervix and placenta. Obstet Gynecol 2000;96(3):337-41
24. Kjellberg L, Hallmans G, Ahren A, Johansson R, Bergman F, Wadell G et al. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra epithelial neoplasia in relation to human papillomavirus infection. BJC 2000;82(7):1332-38.
25. Sukvirach S, Smith J, Tunsakul S, Muñoz N, Keserarat V, Opasatian O et al. Population-based Human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infec Dis 2003;187:1246-56.
26. Hagensee M, Slavinski J, Gaffga C, Suros J, Kissinger P, Martin D. Seroprevalence of human papillomavirus type 16 in pregnant women. Obstet Gynecol 1999;94(5):653-58.
27. Chang-Claude J, Schneider A, Smith E, Blettner M, Wahrendorf J, Turek L. Longitudinal study of the effects of pregnancy and other factor on detection of HPV. Gynecologic Oncology 1996;60:355-62.